GLP1R and diabetes mellitus: Third, the outcome-reducing effect of ERC therapy found in this analysis should be tested in weight-controlled cohorts, especially in patients treated with GLP-1 RAs.37,38 Fourth, management of diabetes used the therapies available during the conduct of the trial.